# This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

> **NCT04267614** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1226 (actual)

## Conditions studied

- Arthritis Rheumatoid

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT04267614
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 1226 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04267614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04267614, "This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04267614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*